Topic - Adar Poonawalla

Related Stories

Vials of AstraZeneca's COVISHIELD vaccine for COVID-19 are seen at a filling lab at the Serum Institute of India, Pune, India, Thursday, Jan. 21, 2021. Experts say there is a pressing need for India to bolster vaccination, which started sluggishly in January. The country is expanding its drive to include everyone over 45 from Thursday, April 1. Spotlight on Serum Institute of India - the world’s largest maker of vaccines and key global supplier - to cater to cases at home has resulted in delays of global shipments of up to 90 million doses under the U.N.-backed COVAX program, an initiative devised to give countries access to vaccines regardless of their wealth. (AP Photo/Rafiq Maqbool)

AP Interview: India could resume vaccine exports by June

By ANIRUDDHA GHOSAL - Associated Press

Indians, some of them, wearing face masks as a precautionary measure against the coronavirus shop at a Sunday market in Jammu, India, Sunday, Jan.3, 2021. India authorized two COVID-19 vaccines on Sunday, paving the way for a huge inoculation program to stem the coronavirus pandemic in the world’s second most populous country. (AP Photo/Channi Anand)

AP Interview: India bars virus vaccine maker from exporting

By ANIRUDDHA GHOSAL - Associated Press

In this undated photograph, employees at the Serum Institute of India, the world’s largest manufacturer of vaccines, work at their facility in Pune, India. (Serum Institute of India via AP) ** FILE **

AP Interview: India vaccine maker sees virus as wake-up call

By ANIRUDDHA GHOSAL - Associated Press